Markets

Institutional Ownership And Insider Trading At UnitedHealth Group Incorporated (UNH)

Institutional Ownership And Insider Trading At UnitedHealth Group Incorporated (UNH)

$990,227 worth of UnitedHealth Group Inc (NYSE:UNH) was sold by WILENSKY GAIL R. 47,500 shares were sold by BURKE RICHARD T, worth $8.23M on Thursday, May 4. After $0.77 actual earnings per share reported by ResMed Inc. for the previous quarter, Wall Street now forecasts -15.58% negative EPS growth. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%.

The biggest institutional shareholders in UnitedHealth Group Incorporated include Vanguard Group Inc which owns 65 million shares in the company valued at $11.97 B million. This showed a surprise of 3.4% in the last quarter earnings. Annual EPS Growth of past 5 years is 8.90%. NAK's distance from 20 day simple moving average is 9.13% and distance from 50-Day simple moving average is 18.41%. Cowen & Co has "Buy" rating and $22000 target. The firm has a market capitalization of $186.80 billion, a P/E ratio of 23.21 and a beta of 0.63.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Highvista Strategies Limited Liability Corporation has 3,100 shares for 0.13% of their portfolio. The ex-dividend date was Thursday the 7th of September 2017. This dividend represents a yield of $1.56. The insider now holds 71,364 shares of UnitedHealth Group Incorporated (UNH).

Receive UnitedHealth Group Incorporated News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated with MarketBeat.com's FREE daily email newsletter. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, September 26th. The consensus rating is 1.5, indicating analysts in general look favorably on the company's future prospects. On July 13 Deutsche Bank kept the stock rating at "Buy" but raised the price expectation from $127.00 to $197.00. The stock has an average rating of "Buy" and an average price target of $205.94. 5,000 shares were sold by BALLARD WILLIAM C JR, worth $913,211. Of those transactions, there were 279,642 shares of UNH bought and 686,687 shares sold. Following the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The transaction was disclosed in a filing with the SEC, which is available at this link. Analyst's mean target price for UNH is $210.56 while analysts mean recommendation is 1.50. The disclosure for this sale can be found here. The stock traded on unusually build up volume of 898795 comparing to the average volume of 1309.70 shares, completing picture of exact trends with uncompleted dots in volume over the norm.

Did Watford's Richarlison dive to win a penalty against Arsenal?
Deeney converted from the spot and Tom Cleverley scored a 92nd-minute victor to send Marco Silva's side fourth in the Premier League .

Since May 4, 2017, it had 0 insider purchases, and 3 insider sales for $10.13 million activity. Teachers Retirement Of The State Of Kentucky stated it has 1.08% in UnitedHealth Group Inc (NYSE:UNH).

Range Resources Corporation (NYSE:RRC) has a market cap of $4.93 billion and over the last 12 months, RRC has declined by -48.63%. UnitedHealth Group had 58 analyst reports since September 2, 2015 according to SRatingsIntel. They set an outperform rating and a $250.00 target price on the stock. Ltd. increased its position in shares of UnitedHealth Group by 433.3% during the second quarter.

In premarket trade, its shares were up 1.50% at US$196.10. First Personal has invested 0.19% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate's stock worth $106,000 after acquiring an additional 603 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in UnitedHealth Group by 2.3% in the second quarter. Insiders own 0.89% of the company's stock. Institutional investors own 86.11% of the company's stock. If you are viewing this news story on another site, it was illegally copied and republished in violation of global trademark and copyright laws. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx.